Underexpression of the 43 kDa inositol polyphosphate 5-phosphatase is associated with spontaneous calcium oscillations and enhanced calcium responses following endothelin-1 stimulation by Speed, CJ et al.
INTRODUCTION
The hydrolysis of phosphatidylinositol 4,5-bisphosphate
(PtdIns(4,5)P2) by phospholipase C to produce the two second
messengers inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) and
diacylglycerol, is a ubiquitous intracellular signalling
mechanism for the mobilisation of intracellular Ca2+ and
activation of protein kinase C (Berridge, 1983, 1993; Berridge
and Irvine, 1984; Majerus, 1992). Ins(1,4,5)P3-induced
increases in intracellular Ca2+ are responsible for a large
number of receptor-initiated signalling pathways in many
cell types, thereby regulating secretion, cytoskeletal
rearrangement, fertilisation and gene transcription (Berridge,
1993, 1995a). Ins(1,4,5)P3 mediates intracellular Ca2+ release
by binding to specific receptors primarily located on the
endoplasmic reticulum. In most cells the rise in intracellular
Ca2+ is associated with oscillatory changes in the free Ca2+
concentration, that are both graded in response and spatially
organised (Berridge, 1993; Clapham, 1995; Thomas et al.,
1996). Sub-maximal doses of Ins(1,4,5)P3 result in quantal or
incremental releases of Ca2+ from the endoplasmic reticulum.
In addition, Ins(1,4,5)P3-mediated Ca2+ release is also
affected by the intracellular Ca2+ concentration ([Ca2+]i).
Increasing cytosolic Ca2+ potentiates Ins(1,4,5)P3-mediated
Ca2+ release, so that at Ca2+ concentrations between 10 nM
and 1 m M they act as co-agonists (Finch et al., 1991; Dawson,
1997).
There are two major pathways for the metabolism of
Ins(1,4,5)P3, which differ in relative importance depending on
the cell type. Ins(1,4,5)P3 can be phosphorylated by an
Ins(1,4,5)P3 3-kinase to form inositol 1,3,4,5-tetrakisphosphate
(Ins(1,3,4,5)P4), which has been implicated in the regulation of
Ca2+ homeostasis in certain cell types (Batty et al., 1985). In
addition, Ins(1,3,4,5)P4 binds with high affinity to Gap1,
synaptotagmin I and II, centaurin a , Btk and a high affinity
Ins(1,3,4,5)P4-binding protein, which has recently been shown
669Journal of Cell Science 112, 669-679 (1999)
Printed in Great Britain © The Company of Biologists Limited 1999
JCS0077
The 43 kDa inositol polyphosphate 5-phosphatase (5-
phosphatase) hydrolyses the signalling molecules inositol
1,4,5-trisphosphate (Ins(1,4,5)P3) and inositol 1,3,4,5-
tetrakisphosphate (Ins(1,3,4,5)P4) and thereby regulates
cellular transformation. To investigate the role Ins(1,4,5)P3-
mediated Ca2+ oscillations play in cellular transformation,
we studied Ins(1,4,5)P3-mediated Ca2+ responses in cells
underexpressing the 43 kDa 5-phosphatase. Chronic
reduction in 43 kDa 5-phosphatase enzyme activity resulted
in a 2.6-fold increase in the resting Ins(1,4,5)P3
concentration and a 4.1-fold increase in basal intracellular
Ca2+. The increased Ins(1,4,5)P3 levels resulted in partial
emptying (40%) of the Ins(1,4,5)P3-sensitive Ca2+ store,
however, store-operated Ca2+ influx remained unchanged.
In addition, Ins(1,4,5)P3 receptors were chronically down-
regulated in unstimulated cells, as shown by a 53%
reduction in [3H]Ins(1,4,5)P3 binding to microsomal
receptor sites. Agonist stimulation with endothelin-1
resulted in the rapid rise and fall of Ins(1,4,5)P3 and
Ins(1,3,4,5)P4 levels, with no significant differences in the
rates of hydrolysis of these second messengers in antisense-
or vector-transfected cells. These studies indicate, in
contrast to its predicted action, the 43 kDa 5-phosphatase
does not metabolise Ins(1,4,5)P3 and Ins(1,3,4,5)P4 post
agonist stimulation. Cells with decreased 43 kDa 5-
phosphatase activity exhibited spontaneous Ca2+
oscillations in the absence of any agonist stimulation, and
increased sensitivity and amplitude of intracellular Ca2+
responses to both high and low dose endothelin-1
stimulation. We conclude the 43 kDa 5-phosphatase exerts
a profound influence on Ins(1,4,5)P3-induced Ca2+ spiking,
both in the unstimulated cell and following agonist
stimulation. We propose the enhanced Ca2+ oscillations
may mediate cellular transformation in cells
underexpressing the 43 kDa 5-phosphatase.
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to encode a GTPase-activating protein (Cullen et al., 1995a,b;
Fukuda et al., 1994, 1996; Hammonds-Odie et al., 1996).
Both second messengers, Ins(1,4,5)P3 and Ins(1,3,4,5)P4,
are inactivated by removal of the 5-position phosphate from the
inositol ring by a family of enzymes known as the inositol
polyphosphate 5-phosphatases (5-phosphatase) (Downes et al.,
1982; Connolly et al., 1985; Mitchell et al., 1989). Nine family
members have been cloned to date and all are characterised by
the presence of a ‘5-phosphatase domain’ (Majerus, 1996;
Mitchell et al., 1996; Woscholski and Parker, 1997). This
domain of approximately 300 amino acids contains two distinct
motifs, WXGDXNXR and PXWCDRXL, located 60 amino
acids apart, which may represent the catalytic or substrate
binding site (Jefferson and Majerus, 1995, 1996; Communi et
al., 1996; Communi and Erneux, 1996).
The 5-phosphatase family includes the 43 kDa 5-
phosphatase (5-phosphatase I), which hydrolyses only
Ins(1,4,5)P3 and Ins(1,3,4,5)P4 (Connolly et al., 1985; Erneux
et al., 1989; Verjans et al., 1992; Laxminarayan et al., 1993).
Other 5-phosphatases such as the 75 kDa 5-phosphatase (5-
phosphatase II), the 5-phosphatase mutated in Lowe’s
syndrome and synaptojanin hydrolyse Ins(1,4,5)P3,
Ins(1,3,4,5)P4, PtdIns(4,5)P2 and PtdIns(3,4,5)P3 (Mitchell et
al., 1989; Matzaris et al., 1994; Jackson et al., 1995; Zhang et
al., 1995; McPherson et al., 1996; Woscholski et al., 1997).
More recently a novel 5-phosphatase designated SHIP (for
SH2-containing 5-phosphatase), that only hydrolyses
Ins(1,3,4,5)P4 and PtdIns(3,4,5)P3 has been characterised
(Damen et al., 1996; Kavanaugh et al., 1996; Lioubin et al.,
1996; Jefferson et al., 1997).
The 43 kDa 5-phosphatase (also called 5-phosphatase I, or
the Type I 5-phosphatase) is the major cellular 5-phosphatase
terminating the signalling function of Ins(1,4,5)P3. Although
the intracellular site for Ins(1,4,5)P3 hydrolysis appears to be
predominantly in the plasma membrane, whether the 43 kDa
5-phosphatase regulates basal Ins(1,4,5)P3 levels, or mediates
the rapid fall in Ins(1,4,5)P3 following agonist stimulation has
yet to be shown. Erneux and colleagues have demonstrated that
overexpression of the 43 kDa 5-phosphatase in Chinese
hamster ovary cells (CHO-K1) abrogates ATP-induced Ca2+
oscillations (De Smedt et al., 1997). Studies in our laboratory
have shown that a chronic reduction in 43 kDa 5-phosphatase
enzyme activity is associated with a transformed phenotype
(Speed et al., 1996). The presumed mechanism mediating
cellular transformation may be enhanced Ins(1,4,5)P3-induced
Ca2+ oscillations, but this has yet to be shown. Furthermore,
correlation between the levels of 43 kDa 5-phosphatase activity
and the size and sensitivity of the Ca2+ oscillatory response has
not yet been demonstrated. In this study we have extended our
characterisation of cell lines that underexpress the 43 kDa 5-
phosphatase. Decreased 43 kDa Ins(1,4,5)P3 5-phosphatase
activity is associated with increased Ins(1,4,5)P3 concentration
in unstimulated cells, resulting in Ins(1,4,5)P3 receptor
activation and subsequent down-regulation. The increased
basal Ins(1,4,5)P3 levels result in spontaneous Ca2+
oscillations, in the absence of agonist stimulation, and
increased sensitivity and amplitude of Ca2+ response to both
low- and high-doses of agonist. Collectively, these results show
the 43 kDa 5-phosphatase critically controls the intensity and
sensitivity of Ins(1,4,5)P3-induced Ca2+ oscillations and we
propose thereby regulates cellular transformation.
MATERIALS AND METHODS
Materials
Dulbecco’s modified Eagle’s medium (DMEM) and tetracycline-HCl
were purchased from ICN Biomedicals, Inc. Geneticin was obtained
from Gibco. Normal rat kidney cells (NRK, clone 49F) were obtained
from American Type Culture Collection. Ortho[32P]phosphoric acid,
[3H]myo-inositol (20.5 Ci/mmol), [3H]Ins(1,4,5)P3 (21 Ci/mmol) and
the inositol 1,4,5-trisphosphate [3H] radioreceptor assay kit were
obtained from Dupont-New England Nuclear. Endothelin-1 (ET-1)
was obtained from Peptide Institute Inc., Japan. Bradykinin and
thapsigargin were from Calbiochem. Fura-2 AM was obtained from
Molecular Probes. All other chemicals were obtained from Sigma.
Transfection of NRK fibroblasts with the 43 kDa inositol
polyphosphate 5-phosphatase
Stable NRK cell lines underexpressing the 43 kDa 5-phosphatase
were generated as previously described (Speed et al., 1996). Briefly,
the 2.6 kb cDNA encoding the 43 kDa membrane-associated 5-
phosphatase was cloned in the antisense orientation into the response
plasmid, pUHD 10-3 of the tetracycline-regulatory expression system
(Gossen and Bujard, 1992). The construct, along with a neomycin
resistance cassette, was stably transfected into NRK cells which
expressed the regulator plasmid pUHD 15-1. Control cells were
simultaneously co-transfected with the pUHD 10-3 plasmid alone and
a neomycin resistance cassette. Cells were cultured in selection
medium containing 0.4 m g/ml geneticin and 2 m g/ml tetracycline-HCl
and antibiotic-resistant clones selected 3-4 weeks later. The presence
of tetracycline (2 m g/ml) in the cell culture medium renders the system
inactive, hence the gene of interest is not expressed. Induction of the
cloned gene is obtained by withdrawing tetracycline from the cell
culture medium for 24 hours.
Cell culture
Cell lines were maintained in DMEM supplemented with 10% fetal
calf serum (FCS), 2 mM glutamine, 100 units/ml penicillin and 0.1%
streptomycin at 37°C in a humidified 5% CO2 atmosphere. Following
stable transfection, NRK cells were cultured in the presence of 2
m g/ml tetracycline-HCl.
Determination of inositol polyphosphate 5-phosphatase
enzyme activity
Cell culture media was aspirated and the adherent cells were washed
three times in imidazole buffer (10 mM imidazole, pH 7.2, containing
1 mM MgCl2, 1 mM EDTA, 0.3 M sucrose, 5 mM 2-mercaptoethanol,
50 m g/ml phenylmethylsulfonyl fluoride). The cells were scraped from
the plate, resuspended in 200 m l imidazole buffer containing 1%
Triton X-100 and sonicated on ice for 60 seconds. The total cell
homogenate was extracted at 4°C with mixing for 2 hours. The sample
was centrifuged at 15,000 g for 10 minutes at 4°C and the supernatant
collected as the Triton-soluble membrane fraction, which was then
assayed for Ins(1,4,5)P3 5-phosphatase activity.
Hydrolysis of Ins(1,[32P]4,[32P]5)P3 was measured by extraction of
released 32PO4 as previously described (Connolly et al., 1985). The
concentration of Ins(1,[32P]4,[32P]5)P3 used in assays was 30 m M, and
was isolated from erythrocyte ghosts as previously described (Downes
et al., 1982).
Measurement of Ins(1,4,5)P3 concentration
Cells were seeded onto 60 mm dishes at a density of 1 · 105 cells/ml
and cultured for 48 hours in the absence of tetracycline in DMEM
containing 10% FCS. Cells were harvested to measure unstimulated
Ins(1,4,5)P3 concentrations, or stimulated with either 60 nM
endothelin-1 (ET-1) or 10 m M bradykinin in Ca2+-containing medium
(20 mM Hepes, pH 7.4, 4 mM KCl, 140 mM NaCl, 1 mM MgCl2, 10
mM glucose, 1.8 mM CaCl2) for various times at 37°C, prior to
harvesting. The solution was aspirated and the reaction terminated by
C. J. Speed and others
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the addition of 500 mM trichloroacetic acid. The cells were scraped
from the dishes in 500 mM trichloroacetic acid and incubated on ice
for 20 minutes prior to centrifugation at 5,000 g for 10 minutes at 4°C.
The supernatant was washed three times with ten volumes of water-
saturated diethyl ether and then neutralised with NaHCO3. The
concentration of Ins(1,4,5)P3 was determined by competition with
[3H]Ins(1,4,5)P3 for microsomal receptor binding sites (Dupont-New
England Nuclear inositol 1,4,5-trisphosphate [3H] radioreceptor assay
kit). Protein measurements were made on unlabelled cells cultured
under identical conditions.
Extraction and separation of [3H]inositol phosphates in
[3H]inositol-labelled fibroblasts
Cells were seeded onto 60 mm dishes at a density of 1 · 105 cells/ml
and cultured for 24 hours in the absence of tetracycline in DMEM
containing 10% FCS. Cells were then labelled with 5 m Ci/ml
[3H]inositol in inositol-free DMEM containing 0.5% FCS for 48
hours. Cells were washed twice in Ca2+-containing medium, followed
by the addition of fresh medium containing 60 nM ET-1 for 15, 30,
60 seconds or 2.5 minutes. The incubation was stopped by removal
of the medium, followed by the addition of 2 ml 3% (v/v) perchloric
acid. The [3H]inositol phosphates were extracted and separated
according to the method described by De Smedt et al. (1997).
Intracellular Ca2+ measurements
Cell monolayers (on coverslips) were cultured for 24-48 hours in the
absence of tetracycline in DMEM containing 10% FCS. Cells were
loaded with 6 m M fura-2 AM in 10% Pluronic detergent for 40
minutes at 37°C in Ca2+-containing medium. The cells on coverslips
were washed 3 times and kept in the dark at room temperature until
use, which was within 1 hour of loading. For population [Ca2+]i
measurements, the coverslip was inserted into a standard cuvette with
Ca2+-containing medium and a stirring device. In the experiments
where Ca2+ was omitted from the medium, 0.1 mM EGTA was added.
The cuvette was placed into a thermostatically controlled chamber at
37°C in a SPEX dual wavelength 1681 fluorolog spectrometer.
Excitation wavelengths were 340 nm and 380 nm, and emitted light
collected at 505 nm. Readings were recorded using dM3000 software
(Spex Industries, Inc., Edison, NJ). Agonists were added by direct
injection of 10 m l volumes of stock solutions into the cuvette. Ca2+
values were corrected for cell autofluorescence at each wavelength by
the addition of 2 m M ionomycin and 2 mM MnCl2. Lanthanum
chloride (LaCl3) was added to a final concentration of 500 m M to
block Ca2+ entry (Cooper et al., 1994; Aussel et al., 1996). [Ca2+]i
was determined as previously described (Neylon et al., 1992).
Single cell [Ca2+]i measurements were performed in Ca2+-
containing medium, using a Nikon Diaphot-TMD fluorescence
microscope equipped with a · 40 oil immersion objective coupled to
the SPEX instrument. The temperature was maintained at 37°C using
a thermostatically controlled microscope stage. Cells were alternately
illuminated at 340 and 380 nm, and the light emitted at 505 nm was
collected by use of a dichroic mirror. Changes in [Ca2+]i were assessed
by calculating the ratio of emitted fluorescence at the excitation
wavelengths, 340 and 380 nm.
Ins(1,4,5)P3 binding assay
Cell lines were cultured to near confluence in 90 mm dishes and then
scraped from the dishes in 10 mM Hepes, pH 7.4, 155 mM NaCl, 1
mM EDTA. A microsomal fraction was prepared by a modification to
the method described by Wojcikiewicz (1995). Cells were centrifuged
at 400 g for 2 minutes at 4°C and resuspended in ice-cold
homogenisation buffer (10 mM Tris, pH 7.4, 1 mM EGTA, 0.2 mM
phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, 10 m M leupeptin)
prior to disruption with a Dounce homogeniser (1 · 10 seconds). Cell
suspensions were centrifuged at 38,000 g for 15 minutes at 4°C and
the microsomal pellets were resuspended in ice-cold homogenisation
buffer.
The Ins(1,4,5)P3 binding assay was performed using 100, 200 or
500 m g of microsomal protein and 2.5 or 5 nM [3H]Ins(1,4,5)P3 in 50
mM Tris-HCl, pH 8, 2 mM EDTA for 15 minutes on ice in a 200 m l
final volume. Bound and free radioligand were separated by
centrifugation at 15,000 g for 5 minutes at 4°C and the pellet washed
once in ice-cold water. Microsomal pellets were solubilised in 1%
Triton X-100 for 15 minutes at 37°C. [3H]Ins(1,4,5)P3 binding was
quantitated by liquid scintillation counting. The specificity of the
assay was determined by competition with 20 m M Ins(1,3,4)P3. Non-
specific binding was determined in the presence of 20 m M
Ins(1,4,5)P3.
Miscellaneous methods
Protein concentrations were performed using Bio-Rad protein assay
with bovine serum albumin as a standard.
RESULTS
Characterisation of cell lines underexpressing the
43 kDa 5-phosphatase
Normal rat kidney (NRK) cells were stably transfected with the
cDNA encoding the 43 kDa 5-phosphatase, cloned in the
antisense orientation into the pUHD 10-3 vector of the tet-
regulatory system, and control cells were transfected with the
pUHD 10-3 vector alone (Speed et al., 1996). We have
observed stable cell lines underexpressing the 43 kDa 5-
phosphatase gradually lose their phenotype with repeat
passaging, due to the incomplete suppression of the antisense
43 kDa 5-phosphatase gene by tetracycline (Speed et al., 1996).
Therefore we have chosen to use vector-transfected clones as
the appropriate controls for all experiments. Cell lines
underexpressing the 43 kDa 5-phosphatase (antisense) were
selected on the basis of a reduction in Ins(1,4,5)P3 5-
phosphatase enzyme activity in the membrane fraction of the
cell, which is the major cellular location for the 43 kDa 5-
phosphatase (Fig. 1A). The Triton-soluble membrane fraction
of antisense-transfected cells, in the absence of tetracycline,
demonstrated a 75% reduction in Ins(1,4,5)P3 5-phosphatase
activity, as compared to control vector-transfected cells
(0.41±0.06 nmol Ins(1,4,5)P3 hydrolysed/minute/mg (n=8)
versus 1.6±0.25 nmol Ins(1,4,5)P3 hydrolysed/minute/mg
(n=7), respectively, P<0.01). Investigation of the Ins(1,4,5)P3
concentration in unstimulated cells was undertaken, as
described in Materials and Methods. The Ins(1,4,5)P3
concentration in antisense-transfected cells was increased
approximately 2.6-fold over that observed in cells transfected
with vector alone (21±2 pmol/mg (n=7) versus 8±1 pmol/mg
(n=6) respectively, P<0.01; Fig. 1B).
Assessment of intracellular Ca2+ levels in antisense-
or vector-transfected NRK cells
The effect of increased cellular Ins(1,4,5)P3 levels on the basal
[Ca2+]i was determined as described in Materials and Methods.
Fura-2 loaded antisense-transfected cells demonstrated a basal
[Ca2+]i of 334±33 nM (n=7) in Ca2+-containing medium with
500 m M LaCl3, a significant increase (4.1-fold, P<0.01) over
vector-transfected cells (81±6 nM, n=13; Fig. 2). LaCl3 was
added to the Ca2+-containing medium to block Ca2+ entry, thus
excluding any contribution of extracellular Ca2+ to the basal
[Ca2+]i. In Ca2+-free medium the validity of the elevated basal
[Ca2+]i of antisense-transfected cells (296±31 nM (n=8) versus
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control cells 83±8 nM (n=7)) was confirmed (3.6-fold,
P<0.01). In addition the basal [Ca2+]i was measured using
Ca2+-free medium containing 0.1 mM EGTA, which lowered
the basal [Ca2+]i of antisense-transfected cells (126±7 nM,
n=14). However, due to the constitutive elevation in
Ins(1,4,5)P3 levels, the basal [Ca2+]i of antisense-transfected
cells still remained significantly higher (1.7-fold, P<0.01) than
vector-transfected cells (74±5 nM, n=13).
The effects of chronically elevated Ins(1,4,5)P3 on the Ca2+
content of the Ins(1,4,5)P3-sensitive store was assessed using
the Ca2+-ATPase inhibitor, thapsigargin (TG). TG has
previously been shown to specifically deplete the Ins(1,4,5)P3-
sensitive, agonist-responsive Ca2+ store in intact cells (Berman
et al., 1994). To assess the optimal TG concentration that
mediates Ca2+ release, a dose-response curve was performed
using fura-2 loaded vector-transfected cells. Maximal stored
Ca2+ was released following the addition of 200 nM TG, with
doses up to 1 m M exhibiting an inhibitory effect (results not
shown). The Ca2+ content of the Ins(1,4,5)P3-sensitive store
was quantitated in antisense- or vector-transfected cells using
200 nM TG in Ca2+-free medium containing 0.1 mM EGTA
(Figs 3 and 4A). Antisense-transfected cells demonstrated a
significant 40% reduction in the Ca2+ content of the
Ins(1,4,5)P3-sensitive store, as compared to vector-transfected
cells (76±6 nM (n=8) versus 121±7 nM (n=8), respectively,
P<0.01). These observations were further supported by similar
experiments performed in Ca2+-containing medium with 500
m M LaCl3. The Ins(1,4,5)P3-sensitive Ca2+ store of antisense-
transfected cells was again reduced by 40%, as compared with
vector-transfected cells (145±27 nM (n=4) versus 248±49 nM
(n=4), respectively).
Assessment of store-operated Ca2+ influx in
antisense- or vector-transfected cells
The effects of increased cytosolic Ca2+ concentration and
depleted Ins(1,4,5)P3-sensitive Ca2+ stores on store-operated
Ca2+ influx were assessed as described in Materials and
Methods. Much experimental data suggests that Ins(1,4,5)P3
stimulates Ca2+ influx either indirectly, as depletion of
intracellular Ca2+ stores releases a diffusible Ca2+ influx factor
(CIF), or directly by interaction of the Ins(1,4,5)P3 receptor
with Ca2+ release activated channels (CRAC) (Berridge,
1995b). Fura-2 loaded cells were treated with 200 nM TG in
Ca2+-free medium containing 0.1 mM EGTA (Fig. 4A). The
addition of extracellular Ca2+ to the TG-treated cells resulted
in rapid capacitative Ca2+ influx, with a subsequent sustained
elevation in [Ca2+]i. However, the rise in [Ca2+]i following the
addition of extracellular Ca2+ was not significantly different
between antisense- or vector-transfected cells (134±18 nM
(n=6) versus 149±14 nM (n=7), respectively; Fig. 4B).
As unstimulated antisense-transfected cells demonstrated a
40% reduction in the Ca2+ content of the Ins(1,4,5)P3-sensitive
C. J. Speed and others
*
0
0.5
1
1.5
2
In
s(1
,4,
5)P
3 
hy
dr
ol
ys
ed
 (n
mo
l/m
in/
mg
)
*
0
5
10
15
20
25
control antisense
In
s(1
,4,
5)P
3 
(pm
ol/
mg
)
A
B
control antisense
Fig. 1. Characterisation of cell lines stably underexpressing the 43
kDa 5-phosphatase. (A) Isolated clones, transfected with the
antisense 43 kDa 5-phosphatase construct (antisense) or with vector
alone (control), were withdrawn from tetracycline 24 hours prior to
the measurement of Ins(1,4,5)P3 5-phosphatase activity in the Triton-
soluble membrane fraction of the cell. Results are the mean and
s.e.m. of three separate experiments using three independent
antisense- or vector-transfected clones. *P<0.01. (B) The
concentration of Ins(1,4,5)P3 in unstimulated antisense or control
cells was measured as described in Materials and Methods. Results
are the mean and s.e.m. from at least six experiments, each
performed in duplicate, using three independent antisense- or vector-
transfected clones. *P<0.01.
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Fig. 2. Measurement of basal [Ca2+]i in NRK cells. Cells were
loaded with 6 m M fura-2 AM and the basal cytosolic Ca2+ levels of
antisense or control cells were measured as described in Materials
and Methods. Measurements were made in Ca2+-containing medium
with 500 m M LaCl3. Results are the mean and s.e.m. of at least seven
measurements, using three independent antisense- or vector-
transfected clones. *P<0.01.
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store, we assessed whether this depletion was sufficient to
induce store-operated Ca2+ influx, without prior treatment with
TG. Antisense- or vector-transfected cells were incubated in
Ca2+-free medium containing 0.1 mM EGTA, prior to the
addition of extracellular Ca2+ (1.8 mM). No apparent Ca2+
entry was observed for either cell type, suggesting that a 40%
reduction in the Ins(1,4,5)P3-sensitive Ca2+ store is insufficient
to induce Ca2+ influx (results not shown).
Agonist-induced Ins(1,4,5)P3 and Ins(1,3,4,5)P4
formation
In most cellular systems Ins(1,4,5)P3 levels rapidly rise within
1-2 minutes following agonist stimulation and return to basal
levels within 5-10 minutes. As the 43 kDa 5-phosphatase is the
major cellular Ins(1,4,5)P3 5-phosphatase, we predicted cells
underexpressing this enzyme would demonstrate sustained
Ins(1,4,5)P3 levels following agonist stimulation. We examined
agonist-induced Ins(1,4,5)P3 formation during a time course of
stimulation using either 60 nM endothelin-1 (ET-1) (Fig. 5A),
or 10 m M bradykinin (Fig. 5B). In both vector- and antisense-
transfected cells, Ins(1,4,5)P3 levels rose rapidly within the first
minute following either ET-1 or bradykinin stimulation and
returned to pre-stimulation levels within 10 minutes. A second
rise in Ins(1,4,5)P3 concentration was routinely observed in
antisense-transfected cells, approximately 5 minutes after the
addition of 60 nM ET-1. Although the basal Ins(1,4,5)P3
concentration was elevated approximately three-fold in
antisense-transfected cells, the rate of fall in the Ins(1,4,5)P3
concentration to pre-stimulation levels was not delayed in cells
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Fig. 3. Assessment of Ins(1,4,5)P3-sensitive Ca2+ store by treatment
with thapsigargin. Cytosolic Ca2+ responses were measured in fura-
2-loaded cells in response to thapsigargin (TG) as described in
Materials and Methods. Results are expressed as the rise in [Ca2+]i
following treatment with 200 nM TG in Ca2+-free medium with 0.1
mM EGTA and represent the mean and s.e.m. of eight experiments,
using three independent antisense- or vector-transfected clones.
*P<0.01.
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Fig. 4. Assessment of store-operated
Ca2+ influx in antisense- or vector-
transfected cells. Cells were loaded with
6 m M fura-2 AM in Ca2+-containing
medium as described in Materials and
Methods. The Ca2+-containing medium
was replaced with Ca2+-free medium
containing 0.1 mM EGTA, immediately
prior to the commencement of the trace.
(A) TG (200 nM) was added at 60
seconds (left arrow) to deplete the
Ins(1,4,5)P3-sensitive Ca2+ store and
Ca2+ influx was initiated by the addition
of 1.8 mM CaCl2 at 200 seconds (right
arrow). Each trace is representative of at
least six experiments, using three
independent antisense- or vector-
transfected clones. (B) Rise in [Ca2+]i
(store-operated Ca2+ influx) following
the addition of 1.8 mM CaCl2. Results
are the mean and s.e.m. of at least six
measurements, using three independent
antisense- or vector-transfected clones.
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underexpressing the 43 kDa 5-phosphatase. In addition, the
Ins(1,4,5)P3 (pmol/mg) released following agonist stimulation
did not differ significantly in cells underexpressing the 43 kDa
5-phosphatase, compared to control cells. These findings were
further substantiated by the analysis of agonist-induced
[3H]Ins(1,4,5)P3 and [3H]Ins(1,3,4,5)P4 formation during a
time course of stimulation using 60 nM ET-1 (Fig. 5C and D,
respectively). Ins(1,3,4,5)P4 is a major substrate of the 43 kDa
5-phosphatase. Elevated basal [3H]Ins(1,4,5)P3 and
[3H]Ins(1,3,4,5)P4 levels rose rapidly within the first minute
following stimulation and returned to near pre-stimulation
levels within 2.5 minutes. The release of [3H]Ins(1,4,5)P3 and
[3H]Ins(1,3,4,5)P4 following agonist stimulation and the rates
of decay of the [3H]inositol phosphates again did not differ
significantly in cells underexpressing the 43 kDa 5-
phosphatase. Collectively these studies demonstrate that the
fall in Ins(1,4,5)P3 and Ins(1,3,4,5)P4 post agonist-stimulation
cannot be attributed to the 43 kDa 5-phosphatase, and may
result from the action of other Ins(1,4,5)P3 5-phosphatases, or
other mechanisms of Ins(1,4,5)P3 metabolism.
Changes in [Ca2+]i in response to a maximal
concentration of ET-1
The addition of ET-1 to NRK cells has been shown to result in
the rapid generation of Ins(1,4,5)P3 and an increase in [Ca2+]i
mediated by the ET-A receptors (Suzaki et al., 1997). Single-
cell [Ca2+]i responses to a maximal dose of ET-1 (60 nM) were
measured in fura-2 loaded antisense- or vector-transfected cells
as described in Materials and Methods (Fig. 6A). Vector-
transfected cells demonstrated varying [Ca2+]i responses to ET-
1 stimulation. Approximately 30% of cells showed no response,
35% demonstrated a single Ca2+ spike, 23.5% showed an initial
Ca2+ spike followed by three smaller Ca2+ transients and 12%
displayed an oscillatory response. The proportion of responders
and the oscillatory patterns observed in vector-transfected cells
did not alter significantly with increasing doses of ET-1 up to
300 nM (results not shown). In contrast, antisense-transfected
cells revealed a marked increase in sensitivity to 60 nM ET-1,
with all but 6% of the cells responding. Of the antisense-
transfected cells examined, 50% displayed a single Ca2+ spike,
25% showed an initial Ca2+ peak followed by two-three
transients and 19% displayed an oscillatory response. In
addition, the amplitude of the Ca2+ response was markedly
enhanced. The mean rise of the initial Ca2+ peak, or Ca2+
oscillations following stimulation with 60 nM ET-1, were
quantitated and are depicted in Fig. 6B. The initial Ca2+ peak
of antisense-transfected cells following stimulation was
increased 1.7-fold (P<0.05) over vector-transfected cells
(fluorescence ratios of 6.1±1.1 (n=15) versus 3.51±0.51 (n=12),
respectively). In addition, the Ca2+ oscillations that followed the
initial peak were significantly larger in amplitude (2.2-fold,
P<0.05) in cells underexpressing the 43 kDa 5-phosphatase,
than those of vector-transfected cells (fluorescence ratios of
1.46±0.32 (n=7) versus 0.66±0.13 (n=14), respectively).
Changes in [Ca2+]i in response to a sub-maximal
concentration of ET-1
Single-cell [Ca2+]i responses to a sub-maximal dose of ET-1 (1
nM) were also measured in fura-2 loaded antisense- or vector-
transfected cells as described in Materials and Methods (Fig.
C. J. Speed and others
Fig. 5. Time course of agonist-
induced Ins(1,4,5)P3 and
Ins(1,3,4,5)P4 formation.
(A,B) Time courses of
Ins(1,4,5)P3 formation
(pmol/mg) in antisense (m) or
control (d) cells were performed
using 60 nM ET-1 (A) or 10 m M
bradykinin (B) as described in
Materials and Methods. The
concentration of Ins(1,4,5)P3
was measured at the indicated
time points. (C,D) Cells were
labelled with [3H]inositol and
time courses of stimulation of
antisense or control cells were
performed using 60 nM ET-1 as
described in Materials and
Methods. The levels of
[3H]Ins(1,4,5)P3 (C) or
[3H]Ins(1,3,4,5)P4 (D) were
measured at the indicated time
points. The results are
normalised with respect to total
[3H]PtdIns. Results shown are
one representative experiment,
from a total of three for each
agonist, using two independent
antisense- or vector-transfected
clones.
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7A). The antisense-transfected cells showed a similar
oscillatory pattern to the control cells, however, the intensity
and proportion of responders was markedly enhanced. Of the
vector-transfected cells examined, 24% of cells exhibited fewer
than 4 Ca2+ spikes which occurred at irregular time intervals,
while 19% of cells displayed an oscillatory pattern of varying
intensity. The majority of vector-transfected cells (57%) failed
to respond to 1 nM ET-1. In contrast, 95% of antisense-
transfected cells responded to 1 nM ET-1 and displayed three
types of oscillatory responses with 21% of cells responding
with regular sharp Ca2+ spikes, 63% with multiple Ca2+ spikes
of varying intensity and 11% with an initial Ca2+ spike
followed by erratic Ca2+ transients. In addition, the amplitude
of the Ca2+ oscillations in response to 1 nM ET-1 were
substantially enhanced (1.5-fold, P<0.05) in antisense-
transfected cells compared to vector-transfected cells
(fluorescence ratios of 0.73±0.07 (n=42) versus 0.5±0.05
(n=26), respectively; Fig. 7B). There were no significant
differences in the frequency of Ca2+ oscillations between
antisense- or vector-transfected cells (results not shown). The
requirement for Ca2+ influx to maintain ET-1-induced Ca2+
spiking was assessed by blocking extracellular Ca2+ entry
using 500 m M LaCl3 (Fig. 8). The blockage of Ca2+ influx
resulted in the progressive inhibition of ET-1-induced [Ca2+]i
oscillations in both antisense- and vector-transfected cells.
Single-cell [Ca2+]i responses to low dose ET-1 were also
assessed in fura-2 loaded antisense- or vector-transfected cells.
Doses of ET-1 in the picomolar range (0.4-0.8 nM) failed to
induce Ca2+ responses in either antisense- or vector-transfected
cells (results not shown).
Cells underexpressing the 43 kDa 5-phosphatase
exhibit spontaneous Ca2+ oscillations
Approximately 14% of cells underexpressing the 43 kDa 5-
phosphatase were found to spontaneously oscillate in the
absence of agonist stimulation. The oscillatory Ca2+ responses
varied in frequency and intensity, however the magnitude of
the responses were decreased compared to agonist-induced
Ca2+ oscillations (Fig. 9). None of the vector-transfected cells
were found to oscillate spontaneously.
Binding of [3H]Ins(1,4,5)P3 to the microsomal
fraction of antisense- or vector-transfected cells
To analyse the expression of Ins(1,4,5)P3 receptors in the
microsomal fraction of antisense- or vector-transfected cells,
[3H]Ins(1,4,5)P3 binding assays were performed as described
in Materials and Methods. Ins(1,4,5)P3 binding sites were
detected using 2.5-5 nM [3H]Ins(1,4,5)P3 as a ligand and non-
specific binding was determined in the presence of 20 m M
unlabelled Ins(1,4,5)P3. To confirm the specificity of the assay,
unlabelled Ins(1,3,4)P3 (20 m M) was unable to effectively
compete with [3H]Ins(1,4,5)P3 for microsomal binding sites
(results not shown). Ins(1,4,5)P3 binding to the microsomal
fraction of antisense-transfected cells was significantly reduced
(53%, P<0.01), compared to vector-transfected cells (8±1 fmol
Ins(1,4,5)P3 bound/mg (n=15) versus 17±3 fmol Ins(1,4,5)P3
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Fig. 6. Single-cell [Ca2+]i responses to 60 nM ET-1. Cells were
loaded with fura-2 and single-cell [Ca2+]i measurements were
performed as described in Materials and Methods.
(A) Representative traces are shown together with the percentage of
the cells showing the specific response. The time points of ET-1
addition are indicated by the arrows. The results are expressed as a
ratio of fura-2 fluorescence. The number of cells examined were 17
control and 16 antisense, from three independent antisense- or
vector-transfected cell clones. (B) Amplitude of initial Ca2+ peak or
Ca2+ oscillations following treatment with 60 nM ET-1. Results are
expressed as the rise in the ratio of fura-2 fluorescence and represent
the mean and s.e.m. of at least seven measurements, using three
independent antisense- or vector-transfected clones. *P<0.05.
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bound/mg (n=9), respectively). These results indicate that the
elevation in Ins(1,4,5)P3 and [Ca2+]i observed in antisense-
transfected cells induces down-regulation of the Ins(1,4,5)P3
receptors (Hajnoczky and Thomas, 1994; Wojcikiewicz, 1995).
We also attempted to analyse Ins(1,4,5)P3 receptor expression
by western blotting the microsomal fractions with antibodies
to the three receptor isoforms. Due to a consistently low signal,
we were unable to convincingly determine the concentration of
each receptor isoform and correlate this with Ins(1,4,5)P3
binding (results not shown).
DISCUSSION
The precise cellular mechanisms by which the major
Ins(1,4,5)P3 5-phosphatase, the 43 kDa enzyme, regulates
Ins(1,4,5)P3 levels are currently being delineated. The results
of the present study demonstrate changes in the expression of
the 43 kDa 5-phosphatase lead to dramatic alterations in
intracellular Ca2+ homeostasis. Reduction in 43 kDa 5-
phosphatase enzyme activity results in elevated basal levels of
Ins(1,4,5)P3, leading to spontaneous Ca2+ oscillations, in the
absence of agonist stimulation, and significantly enhanced
sensitivity of receptor agonists to induce cytoplasmic Ca2+
oscillations. As these effects do not involve alterations in Ca2+
influx, or the rate of fall of Ins(1,4,5)P3 or Ins(1,3,4,5)P4
following agonist stimulation, we conclude that
underexpression of the 43 kDa 5-phosphatase plays a critical
role in regulating the Ca2+ mobilising second messengers in
the unstimulated cell.
Erneux and colleagues have shown that overexpression of
the 43 kDa 5-phosphatase in CHO-K1 cells results in the
abrogation of Ca2+ oscillations in response to 1 m M ATP,
presumably due to increased hydrolysis of Ins(1,4,5)P3 by the
43 kDa 5-phosphatase in the plasma membrane and the
subsequent inability of Ins(1,4,5)P3 to reach the receptor
located in the endoplasmic reticulum (De Smedt et al., 1996,
1997). However these studies did not demonstrate, as we have
shown, that the 43 kDa 5-phosphatase controls both the
amplitude of Ca2+ responses and sensitivity to agonist-induced
Ca2+ oscillations, by regulating the basal Ins(1,4,5)P3
concentration. We propose the increased basal Ins(1,4,5)P3
concentration activates the Ins(1,4,5)P3 receptors in the
unstimulated cell, leading to spontaneous Ca2+ oscillations.
Although the subsequent agonist-induced release of
Ins(1,4,5)P3 is not exaggerated in cells underexpressing the 43
kDa 5-phosphatase and its fall to pre-stimulation levels is not
delayed, the cumulative increase in Ins(1,4,5)P3 results in
markedly enhanced sensitivity to agonists, and doubling of the
amplitude of initial Ca2+ spikes and subsequent oscillations.
It is noteworthy that although cells underexpressing the 43
kDa 5-phosphatase clearly have enhanced Ca2+ responses in
the absence of agonist stimulation, neither complete
Ins(1,4,5)P3 receptor, inactivation or complete emptying of the
Ca2+ stores was observed. Ins(1,4,5)P3 receptor activation and
subsequent down-regulation clearly occurs in unstimulated
cells underexpressing the 43 kDa 5-phosphatase, as
C. J. Speed and others
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Fig. 7. Single-cell [Ca2+]i responses to 1 nM ET-1. Cells were loaded
with fura-2 and single-cell [Ca2+]i measurements were performed as
described in Materials and Methods. (A) Representative traces are
shown together with the percentage of the cells showing the specific
response. The time points of ET-1 addition are indicated by the
arrows. The results are expressed as a ratio of fura-2 fluorescence.
The number of cells examined were 21 control and 19 antisense,
from three independent antisense- or vector-transfected cell clones.
(B) Amplitude of Ca2+ oscillations induced by 1 nM ET-1. Results
are expressed as the rise in the ratio of fura-2 fluorescence and
represent the mean and s.e.m. of at least 26 measurements, using
three independent antisense- or vector-transfected clones. *P<0.05.
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demonstrated by a 53% decrease in [3H]Ins(1,4,5)P3 binding
to the microsomal fraction. In most cellular systems a delayed
Ins(1,4,5)P3 receptor inactivation is observed following
agonist-induced rises in cytosolic Ca2+ (Dufour et al., 1997;
Hajnoczky and Thomas, 1997; Marchant and Taylor, 1997).
Down-regulation of the Ins(1,4,5)P3 receptor is in part an
adaptive process as a consequence of accelerated Ins(1,4,5)P3
receptor degradation. Although all three receptor subtypes (I,
II and III) have been shown to be down-regulated, each
isoform shows different sensitivity to degradation, with the
Type II receptor being relatively resistant (Wojcikiewicz,
1995). We were unable to demonstrate by western analysis
using isotype specific antibodies, Ins(1,4,5)P3 receptor
expression even in vector-transfected cells. This may relate to
relatively low level receptor expression in NRK cells. Despite
the decreased expression of the Ins(1,4,5)P3 receptor,
exaggerated Ca2+ responses were still observed in cells
underexpressing the 43 kDa 5-phosphatase following
endothelin-1 stimulation. Recent studies have suggested a
model for inactivation of the Ins(1,4,5)P3 receptor, proposing
this is associated with conversion of the receptor to a low
affinity activatable state, rather that complete inactivation of
the receptor (Marchant and Taylor, 1997), and thereby Ca2+
release still may occur.
The Ins(1,4,5)P3-sensitive Ca2+ store was significantly
(40%, P<0.01) depleted in cells underexpressing the 43 kDa 5-
phosphatase. We propose the elevated Ins(1,4,5)P3
concentration increases the sensitivity of the Ins(1,4,5)P3
receptors to induce Ca2+ release which partially empties the
store, but this is not sufficient to activate Ca2+ influx. Recent
investigations have suggested that there are two types of
functional Ins(1,4,5)P3-sensitive Ca2+ stores, one involved in
Ca2+ release and another primarily responsible for the
activation of Ca2+ influx (Parekh et al.,1997). In this study
dialysis of Ins(1,4,5)P3 (60-600 nM) into rat basophilic
leukemia cells significantly reduced the Ca2+ content of the
stores without activating Ca2+ entry, consistent with our
observations.
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Fig. 8. Ca2+ oscillations induced by ET-1 are dependent on
extracellular Ca2+ entry. Cells were loaded with fura-2 and single-
cell [Ca2+]i measurements were performed as described in Materials
and Methods. Addition of ET-1 (1 nM) is indicated by the left
arrows. LaCl3 (500 m M) was added subsequently to block Ca2+ entry
(right arrows). Results are expressed as a fura-2 fluorescence ratio.
Each trace is representative of at least four similar traces, using three
independent antisense- or vector-transfected clones.
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Fig. 9. Cells underexpressing the 43 kDa 5-phosphatase exhibit
spontaneous Ca2+ oscillations. Single-cell [Ca2+]i measurements
were made on fura-2 loaded cells as described in Materials and
Methods. Each trace depicts the typical oscillatory pattern displayed
by antisense cells. The results are expressed as a ratio of fura-2
fluorescence. These results were obtained using three independent
antisense-transfected clones.
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An unexpected finding from our studies was the observation
that, despite a profound decrease in Ins(1,4,5)P3 5-phosphatase
enzyme activity, the rate of decline of agonist-induced
increases in Ins(1,4,5)P3 and Ins(1,3,4,5)P4 levels was not
altered. These results show that the 43 kDa 5-phosphatase does
not mediate the fall in these second messengers following
agonist stimulation. A 2-3-fold elevation in Ins(1,4,5)P3 may
increase the maximal activity of other 5-phosphatases, such as
the 75 kDa enzyme (5-phosphatase II) or synaptojanin, which
also hydrolyse Ins(1,4,5)P3 and Ins(1,3,4,5)P4 (Mitchell et al.,
1989; McPherson et al., 1996; Matzaris et al., 1998). In support
of this, we have shown that approximately 20% of the total
cellular Ins(1,4,5)P3 5-phosphatase may be attributed to the
recombinant 5-phosphatase II, as assessed by
immunoprecipitation of NRK vector-transfected cell lysates
using antibodies to this isoform (results not shown). An
alternate explanation for the fall in Ins(1,4,5)P3 concentration
post-agonist stimulation may relate to increased conversion of
Ins(1,4,5)P3 into Ins(1,3,4,5)P4 by the Ins(1,4,5)P3 3-kinase.
Several studies have shown that the 3-kinase is activated by
increasing levels of [Ca2+]i (Rossier et al., 1987; Zilberman et
al., 1987; Dupont and Erneux, 1997). [3H]Ins(1,3,4,5)P4 levels
were consistently elevated approximately 1.5-fold in cells
underexpressing the 43 kDa 5-phosphatase. However, as the 43
kDa 5-phosphatase hydrolyses Ins(1,3,4,5)P4, it is unclear
whether elevation in Ins(1,3,4,5)P4 occurs via enhanced
activation of the Ins(1,4,5)P3 3-kinase enzyme, or as a result
of decreased hydrolysis of this second messenger.
We have previously shown that cells underexpressing the 43
kDa 5-phosphatase have a transformed phenotype (Speed et al.,
1996). Decreased Ins(1,4,5)P3 5-phosphatase activity is
observed in several human acute and chronic leukemia’s,
although the identity of the 5-phosphatase enzymes involved
has not been defined (Nye et al., 1992; Mengubas et al., 1994).
Recent studies have revealed that the amplitude, duration and
frequency of Ca2+ signals contribute to transcriptional
activation and specificity (Dolmetsch et al., 1997, 1998;
Berridge, 1997; Li et al., 1998; Meldolesi, 1998). Low
sustained concentrations of intracellular Ca2+ activate the
nuclear factor of activated T cells (NFAT), whilst large Ca2+
transients activate transcriptional factors such as NF- K B and c-
Jun kinase. The frequency of calcium oscillations are also
specific for gene transcription, differentially regulating both
the efficiency and selectivity of gene activation. In addition,
frequency-specific effects of intracellular Ca2+ oscillations
have been implicated in neuronal differentiation (Gu and
Spitzer, 1995). We predict the spontaneous Ca2+ oscillations
and the enhanced agonist-induced Ca2+ spiking observed in
cells underexpressing the 43 kDa 5-phosphatase results in
differential activation of transcription factors that regulate
cellular transformation.
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